Shi Liang
Impact in
-
- MicroRNA in disease regulation
-
- Breast Lesions and Carcinomas
Papers in
-
- RNA Interference and Gene Delivery 3
- Surgery 6
- Co-authors
- Junmeng Zheng (10 shared papers)Yandan Yao (3 shared papers)Hongbin Gao (4 shared papers)Jiaqi Li (2 shared papers)Wei Wu (3 shared papers)Lijuan Wen (2 shared papers)Baoyong Gong (2 shared papers)Xilong Wang (2 shared papers)
- Journals
- Oxidative Medicine and Cellular Longevity (2 papers)Frontiers in Pharmacology (2 papers)Nature Communications (1 paper)Biochemical and Biophysical Research Communications (1 paper)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Shi Liang
26 papers receiving 528 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 78
- Pathology and Forensic Medicine 70
- Clinical Biochemistry 27
- Molecular Biology 260
- Cardiology and Cardiovascular Medicine 67
Countries citing papers authored by Shi Liang
This map shows the geographic impact of Shi Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Liang more than expected).
Fields of papers citing papers by Shi Liang
This network shows the impact of papers produced by Shi Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Liang. The network helps show where Shi Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shi Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 96 | |
| 2 | 2015 | 61 | |
| 3 | 2019 | 59 | |
| 4 | 2019 | 50 | |
| 5 | 2019 | 44 | |
| 6 | 2019 | 31 | |
| 7 | 2024 | 29 | |
| 8 | 2021 | 25 | |
| 9 | 2021 | 19 | |
| 10 | 2022 | 17 | |
| 11 | 2018 | 17 | |
| 12 | 2014 | 14 | |
| 13 | 2022 | 13 | |
| 14 | 2016 | 13 | |
| 15 | 2022 | 8 | |
| 16 | 2022 | 8 | |
| 17 | 2017 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2020 | 4 |
About Shi Liang
Shi Liang is a scholar working on Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine, Epidemiology and Immunology, having authored 28 papers that have together received 534 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (4 papers), RNA Interference and Gene Delivery (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Metabolism and Genetic Disorders (2 papers), Nanoparticle-Based Drug Delivery (2 papers), interferon and immune responses (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Breast Lesions and Carcinomas (2 papers). The work is most often cited by research in Cancer Research (78 citations), Pathology and Forensic Medicine (70 citations), Clinical Biochemistry (27 citations), Molecular Biology (260 citations) and Cardiology and Cardiovascular Medicine (67 citations). Shi Liang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Junmeng Zheng, Yandan Yao, Hongbin Gao, Jiaqi Li, Wei Wu, Lijuan Wen, Baoyong Gong, Xilong Wang, Xiaolong Yuan and Junxiong Qiu. Their work appears in journals such as Oxidative Medicine and Cellular Longevity, Frontiers in Pharmacology, Nature Communications, Biochemical and Biophysical Research Communications and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.